Customer Portfolio
Who consumes what, at what margin, and who needs attention
Portfolio opportunity identified
Customer growth, margin and churn signals are now visible in one view.
Booked revenue (30d)
$2,147,820
▲ 14.2%
Avg revenue / tenant
$357,970
Net revenue retention
127%
▲ 6 pts
At-risk revenue
$164,220
All customers
Click a row to inspect
| Organisation | Region | Plan | Tokens | Revenue | Margin | Growth | Status |
|---|---|---|---|---|---|---|---|
| Acme Corp | North America | Enterprise | 2.84B | $684,120 | ▲ 18.2% | Active | |
| Globex | Europe | Enterprise | 1.89B | $472,040 | ▲ 12.6% | Active | |
| TechVision | Asia Pacific | Scale | 1.55B | $321,480 | ▲ 9.4% | Active | |
| Innotech Labs | North America | Scale | 987M | $287,310 | ▲ 7.8% | Active | |
| NextGen Health | Middle East | Growth | 743M | $218,650 | ▲ 6.1% | Trial | |
| FinTech Solutions | Europe | Growth | 612M | $164,220 | ▼ 2.4% | At risk |
Token consumption share
Acme
Globex
TechVision
Innotech
NextGen
FinTech
Acme Corp
Enterprise · North America
- Revenue (30d)
- $684,120
- Tokens (30d)
- 2.84B
- Gross margin
- 68%
- Growth
- 18.2%
- Status
- Active
- Namespace
- tenant-acme
Revenue trend
Token trend